Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation, ICOone Nasal, enabling inhalation through the nasal cavities. BioStock reached out to Fredrik Radencrantz, the company’s Director Business Development, to find out more.
Iconovo develops inhalation products in collaboration with international pharmaceutical companies. With solid expertise in the field of inhalation, the company has developed four inhalation platforms that are used for the development of new inhalation drugs and generic drugs.
To read full article at BIO Stock, please click here